Enlivex Therapeutics (Israel) Market Value
| ENLV Stock | ILA 415.10 4.10 0.98% |
| Symbol | Enlivex |
Enlivex Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enlivex Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enlivex Therapeutics.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Enlivex Therapeutics on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Enlivex Therapeutics or generate 0.0% return on investment in Enlivex Therapeutics over 540 days. Enlivex Therapeutics is related to or competes with Lineage Cell, Compugen, Purple Biotech, BioLine RX, Purple Biotech, and Clal Biotechnology. Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company More
Enlivex Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enlivex Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enlivex Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 25.31 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 6.94 |
Enlivex Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enlivex Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enlivex Therapeutics' standard deviation. In reality, there are many statistical measures that can use Enlivex Therapeutics historical prices to predict the future Enlivex Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | 4.8 |
Enlivex Therapeutics Backtested Returns
Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0309, which denotes the company had a -0.0309% return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Standard Deviation of 4.21, variance of 17.69, and Mean Deviation of 2.96 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0511, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Enlivex Therapeutics are expected to decrease at a much lower rate. During the bear market, Enlivex Therapeutics is likely to outperform the market. At this point, Enlivex Therapeutics has a negative expected return of -0.14%. Please make sure to confirm Enlivex Therapeutics' treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Enlivex Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.23 |
Weak predictability
Enlivex Therapeutics has weak predictability. Overlapping area represents the amount of predictability between Enlivex Therapeutics time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enlivex Therapeutics price movement. The serial correlation of 0.23 indicates that over 23.0% of current Enlivex Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.23 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 120.2 K |
Enlivex Therapeutics lagged returns against current returns
Autocorrelation, which is Enlivex Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enlivex Therapeutics' stock expected returns. We can calculate the autocorrelation of Enlivex Therapeutics returns to help us make a trade decision. For example, suppose you find that Enlivex Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Enlivex Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enlivex Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enlivex Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enlivex Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Enlivex Therapeutics Lagged Returns
When evaluating Enlivex Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enlivex Therapeutics stock have on its future price. Enlivex Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enlivex Therapeutics autocorrelation shows the relationship between Enlivex Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Enlivex Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Enlivex Stock
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:Check out Enlivex Therapeutics Correlation, Enlivex Therapeutics Volatility and Enlivex Therapeutics Alpha and Beta module to complement your research on Enlivex Therapeutics. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.